Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| CELG | Celgene Corporation | 0.77% | 89.33 | 1.3% | $810.15m | |
| AMGN | Amgen Inc. | 1.45% | 188.19 | 1.2% | $638.11m | |
| GILD | Gilead Sciences, Inc. | 0.49% | 65.87 | 0.9% | $484.65m | |
| BIIB | Biogen Inc. | 0.88% | 323.98 | 1.3% | $431.18m | |
| ILMN | Illumina, Inc. | 1.40% | 301.02 | 3.5% | $315.69m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 0.66% | 421.39 | 2.6% | $292.10m | |
| VRTX | Vertex Pharmaceuticals Incorporated | 1.07% | 185.03 | 1.9% | $256.31m | |
| ALXN | Alexion Pharmaceuticals, Inc. | 1.04% | 128.87 | 2.0% | $221.95m | |
| SRPT | Sarepta Therapeutics, Inc. | 2.07% | 139.36 | 15.4% | $155.48m | |
| A | Agilent Technologies, Inc. | 0.08% | 77.95 | 1.6% | $150.92m | |
| EXAS | Exact Sciences Corporation | 8.64% | 90.48 | 25.3% | $143.71m | |
| INCY | Incyte Corporation | 1.30% | 84.41 | 2.5% | $113.39m | |
| ARRY | Array BioPharma Inc. | 3.39% | 23.48 | 8.2% | $111.67m | |
| EXEL | Exelixis, Inc. | 0.80% | 21.39 | 6.4% | $82.72m | |
| NBIX | Neurocrine Biosciences, Inc. | 1.86% | 78.75 | 5.1% | $78.66m |
Company Profile
Global Blood Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders. It also provides oral medicines for sickle cell diseases. The company was founded by Matthew P. Jacobson, Andrej Sali, Jack Taunton, Charles J. Homcy, Craig D. Muir and David R. Phillips in February 2011 and is headquartered in South San Francisco, CA.